Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
Revvity (RVTY), What Is Drawing Fresh Attention Now?
Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow
Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today
Revvity to Present at Upcoming Investor Conferences
TD Cowen Maintains Buy on Revvity, Raises Price Target to $175
Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160
Revvity Earnings Preview: What to Expect
William Blair Initiates Coverage On Revvity with Outperform Rating
Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%
Revvity to Host Investor Day
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
Revvity to Hold Earnings Call on November 3, 2026
Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Full Transcript: Revvity Q2 2026 Earnings Call
Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
Revvity Rolls Out GSP T1D 3plex Kit
Is Revvity Stock Outperforming the Dow?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.